Improving Disease Management through Innovative Microbiology Solutions

DeepChek®
Genotyping through NGS & Sanger Sequencing
  • HIV
  • SARS CoV-2
  • HCV
  • TB
  • 16S RNA
More information
UltraGene®
RT-PCR Solutions for Molecular Detection
  • SARS CoV-2
  • Dengue
  • Zika
More information
Digital Solutions
  • Analysis software
  • Data hosting
  • Lab automation
  • Nadis® (Computerized medical record)
More information
Microbiological Specimen Transport and Collection Kits
  • Saliva Preservation Kits
  • Wastewater Collection Kit
  • Surface Collection Kit
  • Inactivation and Preservation Solution
More information
Instruments & Consumables
  • DNA/RNA extraction
  • Real-time PCR systems
  • Liquid handling robots
  • Next-Generation Sequencing (NGS)
  • SANGER sequencing
More information

ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations

https://www.einpresswire.com/article/928571332/abl-diagnostics-selected-by-the-vry-commercial-court-to-acquire-texcell-s-operations

Read More

DeepChek® & HybridChek TB Assays & SoftwareComplete Coverage for Tuberculosis Drug Resistance Testing  by Amplicon & Hybrid Capture NGS Sequencing.

https://mailchi.mp/abldiagnostics/tb2026?e=e8da2024cf

Read More

ABL Diagnostics Confirms BSI Partnership for IVDR Transition and Long-Term Availability of its CE-IVD Medical Devices

https://www.einpresswire.com/article/927085611/abl-diagnostics-confirms-bsi-partnership-for-ivdr-transition-and-long-term-availability-of-its-ce-ivd-medical-devices

Read More

ABL Diagnostics Announces Renewal of U.S. Patent (US 8,859,198 B2) for Hepatitis B Genotyping and Antiviral Resistance

https://www.einpresswire.com/article/919178783/abl-diagnostics-announces-renewal-of-u-s-patent-us-8-859-198-b2-for-hepatitis-b-genotyping-and-antiviral-resistance

Read More

Subscribe to our newsletter

Scroll to Top